The prion protein as a receptor for amyloid-β

Abstract

Arising from: J. Laurén et al. Nature 457, 1128–1132 (2009)10.1038/nature07761; Laurén et al. reply

Increased levels of brain amyloid-β, a secreted peptide cleavage product of amyloid precursor protein (APP), is believed to be critical in the aetiology of Alzheimer’s disease1. Increased amyloid-β can cause synaptic depression2,3, reduce the number of spine protrusions (that is, sites of synaptic contacts)4,5 and block long-term synaptic potentiation (LTP)6,7, a form of synaptic plasticity; however, the receptor through which amyloid-β produces these synaptic perturbations has remained elusive. Laurén et al.8 suggested that binding between oligomeric amyloid-β (a form of amyloid-β thought to be most active5,6,9,10,11) and the cellular prion protein (PrPC)8 is necessary for synaptic perturbations. Here we show that PrPC is not required for amyloid-β-induced synaptic depression, reduction in spine density, or blockade of LTP; our results indicate that amyloid-β-mediated synaptic defects do not require PrPc.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Figure 1: PrP C is not required for amyloid-β-induced synaptic deficits.

References

  1. 1

    Selkoe, D. J. & Schenk, D. Alzheimer’s disease: molecular understanding predicts amyloid-based therapeutics. Annu. Rev. Pharmacol. Toxicol. 43, 545–584 (2003)

  2. 2

    Hsia, A. Y. et al. Plaque-independent disruption of neural circuits in Alzheimer’s disease mouse models. Proc. Natl Acad. Sci. USA 96, 3228–3233 (1999)

  3. 3

    Kamenetz, F. et al. APP processing and synaptic function. Neuron 37, 925–937 (2003)

  4. 4

    Hsieh, H. et al. AMPAR removal underlies Aβ-induced synaptic depression and dendritic spine loss. Neuron 52, 831–843 (2006)

  5. 5

    Shankar, G. M. et al. Natural oligomers of the Alzheimer amyloid-β protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway. J. Neurosci. 27, 2866–2875 (2007)

  6. 6

    Lambert, M. P. et al. Diffusible, nonfibrillar ligands derived from Aβ1–42 are potent central nervous system neurotoxins. Proc. Natl Acad. Sci. USA 95, 6448–6453 (1998)

  7. 7

    Walsh, D. M. et al. Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416, 535–539 (2002)

  8. 8

    Laurén, J., Gimbel, D. A., Nygaard, H. B., Gilbert, J. W. & Strittmatter, S. M. Cellular prion protein mediates impairment of synaptic plasticity by amyloid-β oligomers. Nature 457, 1128–1132 (2009)

  9. 9

    Cleary, J. P. et al. Natural oligomers of the amyloid-β protein specifically disrupt cognitive function. Nature Neurosci. 8, 79–84 (2005)

  10. 10

    Lesné, S. et al. A specific amyloid-β protein assembly in the brain impairs memory. Nature 440, 352–357 (2006)

  11. 11

    Lacor, P. N. et al. Aβ oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer’s disease. J. Neurosci. 27, 796–807 (2007)

  12. 12

    Balducci, C. et al. Synthetic amyloid-β oligomers impair long-term memory independently of cellular prion protein. Proc. Natl Acad. Sci. USA 107, 2295–2300 (2010)

  13. 13

    Kessels, H. W., Kopec, C. D., Klein, M. E. & Malinow, R. Roles of stargazin and phosphorylation in the control of AMPA receptor subcellular distribution. Nature Neurosci. 12, 888–896 (2009)

  14. 14

    Klein, W. L. A. β toxicity in Alzheimer’s disease: globular oligomers (ADDLs) as new vaccine and drug targets. Neurochem. Int. 41, 345–352 (2002)

Download references

Author information

Experimental work was conducted by H.W.K., L.N.N. and S.N.; designed by H.W.K., L.N.N., S.N. and R.M. The manuscript was written by R.M., H.W.K. and L.N.N.

Ethics declarations

Competing interests

Declared none.

PowerPoint slides

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Kessels, H., Nguyen, L., Nabavi, S. et al. The prion protein as a receptor for amyloid-β. Nature 466, E3–E4 (2010). https://doi.org/10.1038/nature09217

Download citation

Further reading

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.